We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
Cap. Flow
-$290M
Cap. Flow %
-2.3%
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
CRM icon
Salesforce
CRM
+$65.4M
3
MRK icon
Merck
MRK
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSB
176
DELISTED
Norbord Inc.
OSB
$16.7M 0.13%
+386,005
New +$14.1M
NBIX icon
177
Neurocrine Biosciences
NBIX
$18.3B
$16.6M 0.13%
161,869
+5,587
+4% +$540K
CMCSA icon
178
Comcast
CMCSA
$86.7B
$16.6M 0.13%
316,420
-93,825
-23% -$4.5M
VRSK icon
179
Verisk Analytics
VRSK
$28.9B
$16.5M 0.13%
79,544
+25,616
+48% +$4.98M
ACAD icon
180
Acadia Pharmaceuticals
ACAD
$4.44B
$16M 0.13%
298,888
-10,112
-3% -$502K
NEO icon
181
NeoGenomics
NEO
$2.04B
$16M 0.13%
296,528
+261,545
+748% +$11.8M
TTEK icon
182
Tetra Tech
TTEK
$8.76B
$15.9M 0.13%
686,775
+151,075
+28% +$3.4M
HASI icon
183
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$15.6M 0.12%
246,603
+7,759
+3% +$397K
INFO
184
DELISTED
IHS Markit Ltd. Common Shares
INFO
$15.6M 0.12%
173,107
+143,586
+486% +$12.4M
MGNX icon
185
MacroGenics
MGNX
$235M
$15.5M 0.12%
676,125
+94,271
+16% +$2.17M
PNC icon
186
PNC Financial Services
PNC
$99.9B
$15.4M 0.12%
103,458
+57,751
+126% +$7.38M
IBM icon
187
IBM
IBM
$214B
$15.2M 0.12%
126,347
-14,633
-10% -$1.69M
NTRS icon
188
Northern Trust
NTRS
$22B
$15.2M 0.12%
162,687
+145,036
+822% +$12.8M
GWPH
189
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15.1M 0.12%
130,547
+22,120
+20% +$2.48M
CHD icon
190
Church & Dwight Co
CHD
$23.6B
$14.8M 0.12%
170,188
+9,667
+6% +$856K
FFIV icon
191
F5
FFIV
$23B
$14.8M 0.12%
84,236
+29,132
+53% +$4.42M
PH icon
192
Parker-Hannifin
PH
$121B
$14.8M 0.12%
54,404
+16,363
+43% +$4.05M
KPTI icon
193
Karyopharm Therapeutics
KPTI
$154M
$14.7M 0.12%
63,439
+28,548
+82% +$6.62M
MET icon
194
MetLife
MET
$62.7B
$14.6M 0.12%
311,128
+49,337
+19% +$2.14M
CHTR icon
195
Charter Communications
CHTR
$16.7B
$14.6M 0.12%
22,061
-233
-1% -$148K
IBN icon
196
ICICI Bank
IBN
$107B
$14.6M 0.12%
979,441
+512,664
+110% +$6.44M
TJX icon
197
TJX Companies
TJX
$178B
$14.5M 0.11%
212,372
-581
-0.3% -$35.3K
ITCI
198
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.5M 0.11%
456,022
+26,022
+6% +$684K
ADP icon
199
Automatic Data Processing
ADP
$111B
$14.4M 0.11%
81,676
-50,955
-38% -$8.37M
TAL icon
200
TAL Education Group
TAL
$6.12B
$14.4M 0.11%
200,812
-102,981
-34% -$7.43M

Similar funds

Candriam SCA's Q4 2020 Portfolio in Review

As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
  • Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
  • Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
  • Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
  • Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
  • Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.